It is also the first study that demonstrates the association of FGF-23, osteopontin, NGAL and sclerostin concentrations with obesity, cardiovascular risk factors, glucose homeostasis and BMR following a 1-year life-style intervention program. This evidence concerns the gene LCN2 and obesity disorder.